EVA logo

Enviva (EVA) Stock

Profile

Country:

United States

IPO:

29 April 2015

Indexes:

Not included

Description:

Enviva is a company that produces and supplies wood pellets, a renewable energy source. They focus on sustainable forestry practices to create pellets from wood waste and low-quality timber. Enviva helps reduce carbon emissions by providing cleaner energy alternatives for power plants and industries.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Oct 08, 2024

Recent annual earnings:

Mar 01, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 17, 2023
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

21 Nov '23 RBC Capital
Sector Perform
16 Nov '23 Raymond James
Market Perform
10 Nov '23 Raymond James
Strong Buy
10 Nov '23 JP Morgan
Underweight
18 Oct '23 JP Morgan
Neutral
04 Oct '23 Truist Securities
Sell
03 Oct '23 Raymond James
Strong Buy
03 Oct '23 RBC Capital
Sector Perform
11 July '23 Citigroup
Buy
15 May '23 RBC Capital
Sector Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
EVA
prnewswire.com17 December 2024

This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income c ountries annually by 2030 INDIANAPOLIS and CAIRO , Dec. 17, 2024 /PRNewswire/ -- The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human and analog insulin to at least one million people annually living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), most of which are in Africa.

Green Thumb: Consistent Growth, Positive EVA, And Bullish Outlook, Buy
Green Thumb: Consistent Growth, Positive EVA, And Bullish Outlook, Buy
Green Thumb: Consistent Growth, Positive EVA, And Bullish Outlook, Buy
EVA
seekingalpha.com23 November 2024

I am bullish on Green Thumb Industries Inc. (GTBIF) due to its consistent revenue growth, strong balance sheet, and aggressive expansion efforts. GTBIF's revenue has grown YoY for seven quarters, despite turbulent profitability, driven by new store openings and market expansion. The company's strong balance sheet, low debt-to-equity ratio, and positive EVA indicate financial health and efficiency, supporting future growth.

Eli Lilly to license arthritis drug to Egypt's EVA Pharma
Eli Lilly to license arthritis drug to Egypt's EVA Pharma
Eli Lilly to license arthritis drug to Egypt's EVA Pharma
EVA
reuters.com04 September 2024

Eli Lilly and Egypt's EVA Pharma have entered into an agreement to license Lilly's rheumatoid arthritis drug in 49 countries in Africa, the companies said on Wednesday.

Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
EVA
prnewswire.com04 September 2024

Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 49 low- to middle-income countries in Africa INDIANAPOLIS and CAIRO , Sept. 4, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and  EVA Pharma  announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated 20,000 people in 49 low- to middle-income countries in Africa by 2030.

EVA Orders GEnx Engines to Power Boeing 787 Fleet Expansion
EVA Orders GEnx Engines to Power Boeing 787 Fleet Expansion
EVA Orders GEnx Engines to Power Boeing 787 Fleet Expansion
EVA
prnewswire.com24 July 2024

FARNBOROUGH, England , July 24, 2024 /PRNewswire/ -- GE Aerospace (NYSE: GE) announced that following EVA Air's recent deal to purchase four Boeing 787-10 Dreamliner aircraft, the airline has placed an order for GEnx engines to power their new aircraft. "We're thrilled EVA has selected our high performance GEnx engine to power its fleet expansion," said Russell Stokes, President and CEO, Commercial Engines and Services, GE Aerospace.

Why Are Stocks Down Today?
Why Are Stocks Down Today?
Why Are Stocks Down Today?
EVA
InvestorPlace14 March 2024

Stocks are down today and investors wonder why have come to the right place as we have the answer to that question! That biggest bit of news keeping stocks down today has to do with inflation.

Enviva Looks Like A Zero
Enviva Looks Like A Zero
Enviva Looks Like A Zero
EVA
Seeking Alpha25 November 2023

Enviva withdrew its full-year guidance and issued a going concern warning, stating it would likely break its debt covenants. A bad contract at the end of last year unexpectedly exposed the company to the spot market, despite the company touting its long-term take-or-pay contracts. Enviva's future prospects depend on a rebound in the spot market for wood pellets and renegotiating its contracts to improve profitability.

Enviva: Time To Show Us The Money
Enviva: Time To Show Us The Money
Enviva: Time To Show Us The Money
EVA
Seeking Alpha13 September 2023

Enviva Inc. has moved lower since our last article and underperformed the S&P 500 by over 22%. Q2 2023 results were a welcome relief for the bulls as the guidance held steady. We go over what the company needs to do to create a meaningful rebound in the stock.

3 Energy Stocks to Sell in September Before They Crash & Burn
3 Energy Stocks to Sell in September Before They Crash & Burn
3 Energy Stocks to Sell in September Before They Crash & Burn
EVA
InvestorPlace04 September 2023

Energy stocks are an essential addition to an investor's diversified portfolio. They garner exposure to different market areas and may offer unique opportunities for significant returns.

Enviva to Participate in Investor Conference
Enviva to Participate in Investor Conference
Enviva to Participate in Investor Conference
EVA
Business Wire17 August 2023

BETHESDA, Md.--(BUSINESS WIRE)--Enviva Inc. (NYSE: EVA) (“Enviva”) today announced members of its management team will attend the Barclays CEO Energy-Power Conference on Tuesday, September 5 and Wednesday, September 6, 2023, in New York City. To view and download the presentation materials being used at these events, please visit ir.envivabiomass.com. About Enviva Enviva Inc. (NYSE: EVA) is the world's largest producer of industrial wood pellets, a renewable and sustainable energy source produc.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of Enviva?
  • What is the ticker symbol for Enviva?
  • Does Enviva pay dividends?
  • What sector is Enviva in?
  • What industry is Enviva in?
  • What country is Enviva based in?
  • When did Enviva go public?
  • Is Enviva in the S&P 500?
  • Is Enviva in the NASDAQ 100?
  • Is Enviva in the Dow Jones?
  • When was Enviva's last earnings report?
  • When does Enviva report earnings?
  • Should I buy Enviva stock now?

What is the primary business of Enviva?

Enviva is a company that produces and supplies wood pellets, a renewable energy source. They focus on sustainable forestry practices to create pellets from wood waste and low-quality timber. Enviva helps reduce carbon emissions by providing cleaner energy alternatives for power plants and industries.

What is the ticker symbol for Enviva?

The ticker symbol for Enviva is NYSE:EVA

Does Enviva pay dividends?

No, Enviva does not pay dividends

What sector is Enviva in?

Enviva is in the Basic Materials sector

What industry is Enviva in?

Enviva is in the Lumber & Wood Production industry

What country is Enviva based in?

Enviva is headquartered in United States

When did Enviva go public?

Enviva's initial public offering (IPO) was on 29 April 2015

Is Enviva in the S&P 500?

No, Enviva is not included in the S&P 500 index

Is Enviva in the NASDAQ 100?

No, Enviva is not included in the NASDAQ 100 index

Is Enviva in the Dow Jones?

No, Enviva is not included in the Dow Jones index

When was Enviva's last earnings report?

Enviva's most recent earnings report was on 8 October 2024

When does Enviva report earnings?

The date for Enviva's next earnings report has not been announced yet

Should I buy Enviva stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions